Omnicell, Inc. [OMCL] stock is trading at $27.79, up 5.27%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The OMCL shares have gain 6.27% over the last week, with a monthly amount drifted -8.74%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 8, February 2024, Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results. In a post published today on Yahoo Finance, Full Year 2023 GAAP Revenues of $1.147 billionFull Year 2023 GAAP net loss of $20 million and GAAP net loss per diluted share of $0.45Full Year 2023 Non-GAAP EBITDA of $138 million and Non-GAAP net income per diluted share of $1.91Full Year 2023 Net Cash Provided by Operating Activities of $181 millionFull Year 2023 Non-GAAP Free Cash Flow of $126 million.
From an analyst’s perspective:
Omnicell, Inc. [NASDAQ: OMCL] stock has seen the most recent analyst activity on January 03, 2024, when Barclays initiated its Underweight rating and assigned the stock a price target of $33. Previously, Wells Fargo upgraded its rating to Equal Weight on November 03, 2023, and dropped its price target to $28. On November 03, 2023, upgrade upgraded it’s rating to Overweight and revised its price target to $39 on the stock. BTIG Research downgraded its rating to a Neutral. KeyBanc Capital Markets downgraded its rating to a Sector Weight. Wells Fargo reiterated a Underweight rating for this stock on September 26, 2023, and downed its price target to $39. In a note dated August 02, 2023, Piper Sandler downgraded an Neutral rating on this stock and boosted its target price from $66 to $70.
Omnicell, Inc. [OMCL] stock has fluctuated between $25.69 and $77.14 over the past year. Currently, Wall Street analysts expect the stock to reach $121.67 within the next 12 months. Omnicell, Inc. [NASDAQ: OMCL] shares were valued at $27.79 at the most recent close of the market. An investor can expect a potential return of 337.82% based on the average OMCL price forecast.
Analyzing the OMCL fundamentals
Omnicell, Inc. [NASDAQ:OMCL] reported sales of 1.15B for the trailing twelve months, which represents a drop of -13.04%. Gross Profit Margin for this corporation currently stands at 0.43% with Operating Profit Margin at -0.03%, Pretax Profit Margin comes in at -0.02%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.02 and Total Capital is -0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.48.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 26.78 points at the first support level, and at 25.77 for the second support level. However, for the 1st resistance point, the stock is sitting at 28.47, and for the 2nd resistance point, it is at 29.15.
Omnicell, Inc. [OMCL] reported earnings per share of $0.33 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.15/share, meaning a difference of $0.18 and a surprise factor of 120.00%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0.62 per share as compared to estimates of $0.47 per share, a difference of $0.15 representing a surprise of 31.90%.
Ratios To Look Out For
For context, Omnicell, Inc.’s Current Ratio is 2.52. Further, the Quick Ratio stands at 2.22, while the Cash Ratio is 1.36. Considering the valuation of this stock, the price to sales ratio is 1.11, the price to book ratio is 1.06.
Transactions by insiders
Recent insider trading involved MELLON CHRISTINE MARIE, EVP, EXECUTIVE ADVISOR, that happened on Jun 09 ’23 when 7951.0 shares were sold. CHAIRMAN, PRESIDENT AND CEO, LIPPS RANDALL A completed a deal on Jun 08 ’23 to buy 4000.0 shares.
